Home Log In
Thursday, October 15, 2026
26.7
C
Bengaluru
Hot topics
72nd Republic Day: What’s the Road Ahead for Indian Pharma?
“We are getting too happy, for too little”: these...
Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals
Simon Rosof has been appointed Head of Asia Pacific...
The Forgotten HisTORy of Surendra Nath Sehgal: Discovery of Rapamycin
From the Soil of Rapa Nui to the Brain’s...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
What ChrysCapital’s Takeover Of Novartis India Really Means
When ChrysCapital, one of India's oldest and largest homegrown...
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Indian Pharma’s Three Deficits—and Three Potential Dividends
Indian pharma has already done the hard thing once.
It...
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Indian Pharma’s Three Deficits—and Three Potential Dividends
Indian pharma has already done the hard thing once.
It...
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Indian Pharma’s Three Deficits—and Three Potential Dividends
Indian pharma has already done the hard thing once.
It...
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Indian Pharma’s Three Deficits—and Three Potential Dividends
Indian pharma has already done the hard thing once.
It...
Hot topics
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
Mounjaro to Orforglipro: Lilly’s $6 Billion Bet on the Next GLP‑1 Revolution
Eli Lilly is in a rare position. Its GLP-1...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
When drones first appeared on battlefields, military establishments reacted...
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Indian Pharma’s Three Deficits—and Three Potential Dividends
Indian pharma has already done the hard thing once.
It...
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Indian Pharma’s Three Deficits—and Three Potential Dividends
Indian pharma has already done the hard thing once.
It...
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Indian Pharma’s Three Deficits—and Three Potential Dividends
Indian pharma has already done the hard thing once.
It...
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Indian Pharma’s Three Deficits—and Three Potential Dividends
Indian pharma has already done the hard thing once.
It...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.
With over two decades of experience across finance, strategy,...
Who Is Accountable for the Medicine in Your Hand?
The Accountability Gap: India’s Drug Regulatory System
Your doctor prescribes...
The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?
The next owner of an Indian hospital may not...
Newsletter
Get important news delivered directly to your inbox and stay connected!